2000
DOI: 10.1034/j.1399-0039.2000.550311.x
|View full text |Cite
|
Sign up to set email alerts
|

Routine HLA‐B genotyping with PCR‐sequence‐specific oligonucleotides (PCR‐SSO) detects eight new alleles: B*0807, B*0809, B*1551, B*3529, B*3532, B*4025, B*5304 and B*5508

Abstract: This paper describes eight new alleles (B*0807, B*0809, B*1551, B*3529, B*3532, B*4025, B*5304 and B*5508) that have been found by routine HLA-B genotyping with sequence-specific oligonucleotides (SSOs). All of the new alleles have variations which cause changes in residues that occur within antigen binding pockets and T-cell recognition sites of the antigen. The new polymorphisms within these new alleles may affect the nature and specificity of peptide binding and cause differential T-cell activation, which m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
2
0

Year Published

2001
2001
2007
2007

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 5 publications
1
2
0
Order By: Relevance
“…The new alleles reported here are in addition to another eight new HLA‐B alleles reported earlier (4), which were detected by routine PCR‐SSO genotyping of HLA Class I genes. PCR‐SSO is a relatively non‐toxic, accurate, reproducible and reliable technique that is particularly suited for HLA Class I genotyping of donors to bone marrow registries or whenever typing a large sample cohort.…”
supporting
confidence: 55%
“…The new alleles reported here are in addition to another eight new HLA‐B alleles reported earlier (4), which were detected by routine PCR‐SSO genotyping of HLA Class I genes. PCR‐SSO is a relatively non‐toxic, accurate, reproducible and reliable technique that is particularly suited for HLA Class I genotyping of donors to bone marrow registries or whenever typing a large sample cohort.…”
supporting
confidence: 55%
“…HLA‐B*5612 was detected in a candidate for bone marrow transplantation initially described as B*46 and B*5508 when using Micro‐SSP HLA class I typing tray (One Lambda, Canoga Park, CA). Since B*5508 allele was first reported in Australian Aboriginal (Kennedy et al ., 2000) and was never observed previously in Taiwan, this HLA‐B typing needed confirming. The new hybridization pattern obtained using the reverse line SSO typing kit (Dynal Biotech, Bromborough, Wirral, UK) revealed two additional positive probes (probe 28 (SHIIQR) and probe 50 (LEGTC)) and suggested that codon 92–97 and codon 160–164 were different from B*5508 (Fig.…”
Section: Introductionmentioning
confidence: 99%
“…Current human leukocyte antigen (HLA) typing strategies detect HLA-B polymorphisms in genomic DNA with sequence-specific primers (SSP) (1,2), sequence-specific oligonucleotides (SSO) (3,4), or sequence-based (SB) typings (4,5). Polymorphisms are not assigned to paternal or maternal haplotypes.…”
mentioning
confidence: 99%